A Rare Case of Severe Congenital RYR1-Associated Myopathy

Congenital myopathies are a group of rare inherited diseases, defined by hypotonia and muscle weakness. We report clinical and genetic characteristics of a male preterm newborn, whose phenotype was characterized by severe hypotonia and hyporeactivity, serious respiratory distress syndrome that required mechanical ventilation, clubfoot, and other dysmorphic features. The diagnostic procedure was completed with the complete exome sequencing of the proband and of his parents and his sister, which showed new mutations in the ryanodine receptor gene (RYR1), which maps to chromosome 19q13.2 and encodes the skeletal muscle isoform of a calcium-release channel in the sarcoplasmic reticulum (RyR1). This report confirms that early diagnosis and accurate study of genomic disorders are very important, enabling proper genetic counselling of the reproductive risk, as well as disease prognosis and patient management.

[1]  P. Barkhaus,et al.  Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy , 2019, Journal of neuropathology and experimental neurology.

[2]  R. Lovering,et al.  Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease , 2016, Front. Physiol..

[3]  B. Engelen,et al.  RYR1‐related myopathies: a wide spectrum of phenotypes throughout life , 2015, European journal of neurology.

[4]  Xiang Li,et al.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.

[5]  Jacqueline Palace,et al.  Congenital myopathies with secondary neuromuscular transmission defects; A case report and review of the literature , 2014, Neuromuscular Disorders.

[6]  Rosário Santos,et al.  Ryanodine myopathies without central cores--clinical, histopathologic, and genetic description of three cases. , 2014, Pediatric neurology.

[7]  Ching H. Wang,et al.  Approach to the diagnosis of congenital myopathies , 2014, Neuromuscular Disorders.

[8]  M. Tarnopolsky,et al.  Genotype-phenotype correlations in recessive RYR1-related myopathies , 2013, Orphanet Journal of Rare Diseases.

[9]  Y. Nevo,et al.  Variable Myopathic Presentation in a Single Family with Novel Skeletal RYR1 Mutation , 2013, PloS one.

[10]  L. Wilkins.  Severe congenital RYR1-associated myopathy: The expanding clinicopathologic and genetic spectrum , 2013, Neurology.

[11]  A. Karch,et al.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2013, Neurology.

[12]  N. Clarke,et al.  Mapping domains and mutations on the skeletal muscle ryanodine receptor channel. , 2012, Trends in molecular medicine.

[13]  K. Bushby,et al.  Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene‐associated myopathies , 2012, Human mutation.

[14]  J. Dowling,et al.  Congenital Myopathies: An Update , 2012, Current Neurology and Neuroscience Reports.

[15]  K. Claeys,et al.  Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization , 2011, Neuropathology and applied neurobiology.

[16]  F. Muntoni,et al.  Core myopathies. , 2011, Seminars in Pediatric Neurology.

[17]  Straub,et al.  RYR1 mutations are a common cause of congenital myopathies with central nuclei , 2010, Annals of neurology.

[18]  A. Marks,et al.  Ryanodine receptor channelopathies , 2010, Pflügers Archiv - European Journal of Physiology.

[19]  A. Laquérriere,et al.  First genomic rearrangement of the RYR1 gene associated with an atypical presentation of lethal neonatal hypotonia , 2009, Neuromuscular Disorders.

[20]  C. Sewry.  Pathological defects in congenital myopathies , 2008, Journal of Muscle Research and Cell Motility.

[21]  F. Muntoni,et al.  Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. , 2008, Current opinion in pharmacology.

[22]  A. Laquérriere,et al.  Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores , 2008, Human mutation.

[23]  Susan C. Brown,et al.  Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. , 2007, Brain : a journal of neurology.

[24]  R. Robinson,et al.  Mutations in RYR1 in malignant hyperthermia and central core disease , 2006, Human mutation.

[25]  E. Bertini,et al.  Characterization of recessive RYR1 mutations in core myopathies. , 2006, Human molecular genetics.

[26]  I. Nonaka,et al.  0261 Central core disease is due to RyR1 mutations in more than 90% of patients , 2005, Journal of the Neurological Sciences.

[27]  N. Romero,et al.  Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia. , 2003, Brain : a journal of neurology.

[28]  A. Lemainque,et al.  A recessive form of central core disease, transiently presenting as multi‐minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene , 2002, Annals of neurology.

[29]  H. Brinkmeier,et al.  Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. , 2000, Physiological reviews.

[30]  M. Phillips,et al.  The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. , 1996, Genomics.